PALONOSETRON

PALONOSETRON was reported 5372 times

PALONOSETRON is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PHARYNGEAL DYSKINESIA 7 0.2414
1 HYPERTENSIVE CARDIOMEGALY 3 0.0938
2 GASTROINTESTINAL DILATION PROCEDURE 3 0.0638
3 SUBCLAVIAN ARTERY OCCLUSION 6 0.0594
4 BILIARY ABSCESS 2 0.0571
5 BURKHOLDERIA INFECTION 3 0.0361
6 BLASTOCYSTIS INFECTION 3 0.0345
7 CONVULSIVE THRESHOLD LOWERED 11 0.0280
8 ATHEROSCLEROTIC PLAQUE RUPTURE 2 0.0274
9 RENAL ISCHAEMIA 14 0.0256
10 COLONY STIMULATING FACTOR THERAPY 5 0.0242
11 VACCINATION SITE REACTION 3 0.0233
12 ISCHAEMIC ENTERITIS 2 0.0206
13 ANAEMIA OF MALIGNANT DISEASE 5 0.0179
14 DYSAESTHESIA PHARYNX 3 0.0171
15 POSTURAL TREMOR 5 0.0171
16 INTRAVASCULAR HAEMOLYSIS 9 0.0161
17 PARASOMNIA 11 0.0153
18 BASOPHIL COUNT DECREASED 4 0.0152
19 HAPTOGLOBIN INCREASED 2 0.0146
20 LICE INFESTATION 3 0.0143
21 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 11 0.0140
22 OROPHARYNGEAL ERYTHEMA 2 0.0137
23 CHOLINERGIC SYNDROME 8 0.0125
24 NAIL PIGMENTATION 3 0.0124
25 SOMATIC DELUSION 3 0.0122
26 ACUTE HEPATITIS B 4 0.0120
27 NECROTISING COLITIS 15 0.0118
28 HAEMOPERITONEUM 9 0.0112
29 AUTOIMMUNE COLITIS 7 0.0109
30 IMMUNE-MEDIATED NEPHRITIS 5 0.0107
31 TRIPLE NEGATIVE BREAST CANCER 7 0.0104
32 EMPHYSEMATOUS CYSTITIS 2 0.0094
33 MYXOEDEMA 2 0.0089
34 AORTITIS 6 0.0087
35 CYSTITIS ESCHERICHIA 3 0.0084
36 NAIL RIDGING 4 0.0076
37 ABDOMINAL WOUND DEHISCENCE 2 0.0073
38 STASIS DERMATITIS 5 0.0073
39 CATHETER SITE THROMBOSIS 2 0.0073
40 CATHETER SITE CELLULITIS 2 0.0068
41 ALOPECIA UNIVERSALIS 2 0.0068
42 FEBRILE INFECTION 8 0.0068
43 HAIR INJURY 2 0.0067
44 DEVICE RELATED BACTERAEMIA 2 0.0065
45 HAIR DISORDER 53 0.0064
46 PROCEDURAL VOMITING 4 0.0062
47 ALOPECIA TOTALIS 2 0.0061
48 PROTEIN-LOSING GASTROENTEROPATHY 3 0.0060
49 FULMINANT TYPE 1 DIABETES MELLITUS 6 0.0058
50 INFUSION SITE VESICLES 3 0.0057
51 CYSTITIS HAEMORRHAGIC 22 0.0055
52 ENTEROCOLITIS INFECTIOUS 5 0.0054
53 BLOOD ALKALINE PHOSPHATASE DECREASED 5 0.0053
54 AORTIC CALCIFICATION 3 0.0052
55 METASTATIC LYMPHOMA 2 0.0051
56 PSYCHOLOGICAL TRAUMA 44 0.0051
57 PROCEDURAL NAUSEA 4 0.0050
58 IMMUNE-MEDIATED DERMATITIS 5 0.0050
59 MEAN PLATELET VOLUME DECREASED 4 0.0048
60 ARTERITIS 3 0.0047
61 HYPOPROTEINAEMIA 9 0.0047
62 SEDATION COMPLICATION 12 0.0047
63 HAIR COLOUR CHANGES 58 0.0047
64 INFLUENZA A VIRUS TEST POSITIVE 2 0.0046
65 ALCOHOL WITHDRAWAL SYNDROME 4 0.0046
66 TRANSFUSION REACTION 4 0.0046
67 BLADDER HYPERTROPHY 2 0.0045
68 ILEAL PERFORATION 3 0.0045
69 HYPOALBUMINAEMIA 35 0.0045
70 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 2 0.0045
71 IMMUNE-MEDIATED HYPOPHYSITIS 2 0.0044
72 ANASTOMOTIC ULCER 2 0.0043
73 HAIR TEXTURE ABNORMAL 58 0.0043
74 HERPES SIMPLEX ENCEPHALITIS 2 0.0043
75 CEREBRAL HYPOPERFUSION 2 0.0043
76 BLOOD PHOSPHORUS ABNORMAL 2 0.0042
77 MONOCYTE PERCENTAGE INCREASED 3 0.0042
78 MADAROSIS 49 0.0042
79 GASTRIC DILATATION 7 0.0042
80 HICCUPS 34 0.0041
81 ABDOMINAL MASS 11 0.0041
82 EVANS SYNDROME 2 0.0041
83 HYPOPHYSITIS 8 0.0040
84 IMMUNE-MEDIATED HEPATITIS 8 0.0039
85 FEBRILE NEUTROPENIA 259 0.0039
86 COLON CANCER METASTATIC 6 0.0037
87 ATRIOVENTRICULAR BLOCK SECOND DEGREE 11 0.0036
88 RECALL PHENOMENON 3 0.0036
89 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 3 0.0036
90 POSTOPERATIVE ILEUS 2 0.0035
91 IMMUNE-MEDIATED ENTEROCOLITIS 13 0.0035
92 TONGUE MOVEMENT DISTURBANCE 3 0.0035
93 PELVIC ABSCESS 4 0.0035
94 PALMAR ERYTHEMA 4 0.0035
95 EXCESSIVE EYE BLINKING 5 0.0034
96 MEDICAL DEVICE SITE INFECTION 2 0.0032
97 IMMUNE THROMBOCYTOPENIC PURPURA 9 0.0032
98 RECTAL FISSURE 2 0.0032
99 ENTEROCOLITIS 18 0.0031
100 IMMUNE-MEDIATED MYOCARDITIS 5 0.0031
101 DRUG CLEARANCE DECREASED 4 0.0031
102 ALOPECIA AREATA 5 0.0028
103 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 28 0.0027
104 COMA HEPATIC 2 0.0027
105 HYPERURICAEMIA 11 0.0027
106 INDIFFERENCE 2 0.0027
107 MALIGNANT ASCITES 2 0.0026
108 IMMUNE-MEDIATED ADVERSE REACTION 4 0.0026
109 HYPOMAGNESAEMIA 36 0.0026
110 GASTRIC PERFORATION 7 0.0026
111 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 2 0.0026
112 VULVOVAGINAL MYCOTIC INFECTION 10 0.0025
113 PANCREATITIS RELAPSING 2 0.0024
114 CYTOKINE RELEASE SYNDROME 49 0.0024
115 RESUSCITATION 4 0.0024
116 ADRENAL MASS 2 0.0024
117 CAMPYLOBACTER INFECTION 2 0.0024
118 NEUTROPENIC SEPSIS 17 0.0024
119 ANAEMIA MACROCYTIC 5 0.0023
120 POLYNEUROPATHY 28 0.0023
121 GASTROINTESTINAL FISTULA 2 0.0023
122 NEUTROPHIL COUNT DECREASED 93 0.0023
123 LYMPHOCYTE PERCENTAGE DECREASED 3 0.0022
124 ADENOCARCINOMA 5 0.0022
125 PNEUMONIA KLEBSIELLA 4 0.0022
126 METASTASES TO ADRENALS 2 0.0022
127 PERIPHERAL MOTOR NEUROPATHY 3 0.0021
128 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 7 0.0021
129 EOSINOPHIL COUNT DECREASED 5 0.0021
130 NEUTROPENIC INFECTION 2 0.0021
131 HEPATIC MASS 4 0.0021
132 PCO2 DECREASED 2 0.0021
133 ONCOLOGIC COMPLICATION 2 0.0021
134 HYPERVIGILANCE 2 0.0021
135 RHEUMATIC DISORDER 4 0.0021
136 PERIPHERAL SENSORY NEUROPATHY 12 0.0021
137 IMMUNE-MEDIATED HEPATIC DISORDER 4 0.0020
138 STRIDOR 6 0.0020
139 DUODENAL PERFORATION 2 0.0020
140 ADMINISTRATION SITE EXTRAVASATION 2 0.0020
141 URINE ABNORMALITY 9 0.0020
142 RESPIRATORY DEPRESSION 24 0.0020
143 CANCER PAIN 5 0.0020
144 MEAN CELL VOLUME INCREASED 5 0.0019
145 BLADDER DYSFUNCTION 2 0.0019
146 HYPOKALAEMIA 88 0.0019
147 HYPOVOLAEMIA 11 0.0019
148 NEUTROPENIA 254 0.0019
149 CYSTITIS INTERSTITIAL 3 0.0019
150 GALLBLADDER ENLARGEMENT 2 0.0019
151 BONE NEOPLASM 2 0.0019
152 INFUSION RELATED REACTION 123 0.0019
153 TONGUE OEDEMA 7 0.0018
154 AORTIC DILATATION 2 0.0018
155 RHINOVIRUS INFECTION 7 0.0018
156 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 3 0.0018
157 PERIARTHRITIS 4 0.0018
158 AORTIC THROMBOSIS 2 0.0017
159 PNEUMONITIS 47 0.0017
160 HYPERAMMONAEMIC ENCEPHALOPATHY 3 0.0017
161 RADIATION SKIN INJURY 2 0.0017
162 PAROTITIS 2 0.0017
163 INFUSION SITE INFECTION 4 0.0017
164 EPIDIDYMITIS 2 0.0017
165 MUCOSAL INFLAMMATION 45 0.0017
166 HYPOCHLORAEMIA 2 0.0017
167 RECTAL ULCER 2 0.0017
168 TYPE I HYPERSENSITIVITY 6 0.0017
169 BONE MARROW TOXICITY 2 0.0017
170 LEUKOPENIA 84 0.0017
171 ORAL CANDIDIASIS 22 0.0017
172 NORMOCHROMIC NORMOCYTIC ANAEMIA 5 0.0017
173 EMBOLISM VENOUS 5 0.0016
174 ESSENTIAL HYPERTENSION 3 0.0016
175 OESOPHAGEAL SPASM 3 0.0016
176 LARGE INTESTINE INFECTION 2 0.0016
177 DIASTOLIC DYSFUNCTION 5 0.0016
178 BLOOD ELECTROLYTES ABNORMAL 2 0.0016
179 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 2 0.0016
180 TUMOUR LYSIS SYNDROME 14 0.0016
181 LIP DISCOLOURATION 2 0.0016
182 METASTASES TO PERITONEUM 4 0.0016
183 MALLORY-WEISS SYNDROME 2 0.0016
184 HEPATITIS B REACTIVATION 5 0.0016
185 HAEMORRHAGE URINARY TRACT 4 0.0016
186 BILIARY OBSTRUCTION 2 0.0015
187 THROMBOTIC MICROANGIOPATHY 15 0.0015
188 MYELOSUPPRESSION 55 0.0015
189 HYPERAEMIA 3 0.0015
190 BACTERAEMIA 18 0.0015
191 GASTROENTERITIS NOROVIRUS 2 0.0015
192 ARTERIOSPASM CORONARY 6 0.0015
193 CYSTITIS NONINFECTIVE 2 0.0015
194 HYPOPHOSPHATAEMIA 11 0.0015
195 GLYCOSURIA 2 0.0015
196 CHOLANGITIS SCLEROSING 3 0.0015
197 SUBILEUS 3 0.0014
198 PROCTITIS 4 0.0014
199 DILATATION VENTRICULAR 3 0.0014
200 THROMBOTIC THROMBOCYTOPENIC PURPURA 5 0.0014
201 FANCONI SYNDROME 2 0.0014
202 BRAIN FOG 22 0.0014
203 DUODENAL ULCER HAEMORRHAGE 4 0.0014
204 GASTROINTESTINAL NECROSIS 4 0.0014
205 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 3 0.0014
206 NORMOCYTIC ANAEMIA 2 0.0014
207 CLOSTRIDIUM TEST POSITIVE 3 0.0014
208 LYMPHOCYTE COUNT DECREASED 24 0.0014
209 APPETITE DISORDER 9 0.0014
210 NEUROPATHY PERIPHERAL 128 0.0013
211 CARDIOTOXICITY 12 0.0013
212 THROMBOCYTOPENIA 149 0.0013
213 MANTLE CELL LYMPHOMA 2 0.0013
214 PNEUMONIA PSEUDOMONAL 2 0.0013
215 DUODENITIS 4 0.0013
216 VENOUS THROMBOSIS 5 0.0013
217 OSTEOSCLEROSIS 2 0.0013
218 SINUS TACHYCARDIA 18 0.0013
219 IDIOPATHIC THROMBOCYTOPENIC PURPURA 2 0.0013
220 PULSE ABSENT 6 0.0013
221 PHARYNGEAL PARAESTHESIA 2 0.0013
222 HYPERBILIRUBINAEMIA 13 0.0013
223 GASTROINTESTINAL TOXICITY 6 0.0012
224 HAEMOLYTIC ANAEMIA 11 0.0012
225 ILEUS 15 0.0012
226 STOMATITIS 73 0.0012
227 PERSECUTORY DELUSION 3 0.0012
228 HYPERAMMONAEMIA 6 0.0012
229 VENOOCCLUSIVE DISEASE 3 0.0012
230 VENTRICULAR HYPERTROPHY 3 0.0012
231 MALIGNANT PLEURAL EFFUSION 2 0.0012
232 IMPAIRED QUALITY OF LIFE 17 0.0012
233 NEUROPATHY 2 0.0012
234 ALOPECIA 229 0.0012
235 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 27 0.0012
236 FAILURE TO THRIVE 6 0.0012
237 DERMATITIS ACNEIFORM 7 0.0011
238 PARONYCHIA 5 0.0011
239 HYPOXIA 40 0.0011
240 IMMUNOSUPPRESSION 10 0.0011
241 UPPER GASTROINTESTINAL HAEMORRHAGE 19 0.0011
242 CHOLANGITIS 7 0.0011
243 ILEUS PARALYTIC 5 0.0011
244 LARYNGOSPASM 3 0.0011
245 PNEUMOMEDIASTINUM 2 0.0011
246 IMMUNE-MEDIATED LUNG DISEASE 2 0.0011
247 IMMUNE THROMBOCYTOPENIA 5 0.0011
248 VENTRICULAR FIBRILLATION 12 0.0011
249 HEPATITIS ACUTE 7 0.0011
250 DRUG TOLERANCE DECREASED 3 0.0011
251 ANAEMIA 203 0.0011
252 SACROILIITIS 2 0.0011
253 SKIN ABRASION 5 0.0011
254 BLOOD BICARBONATE DECREASED 2 0.0011
255 COLITIS ISCHAEMIC 7 0.0010
256 ARTERIAL THROMBOSIS 2 0.0010
257 CARCINOEMBRYONIC ANTIGEN INCREASED 2 0.0010
258 EARLY SATIETY 2 0.0010
259 SPINAL CORD COMPRESSION 4 0.0010
260 PYELONEPHRITIS ACUTE 2 0.0010
261 PNEUMONIA STAPHYLOCOCCAL 2 0.0010
262 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 6 0.0010
263 CELL DEATH 2 0.0010
264 BLOOD ALBUMIN DECREASED 8 0.0010
265 GINGIVAL PAIN 8 0.0010
266 ANORECTAL DISORDER 2 0.0010
267 ATYPICAL PNEUMONIA 3 0.0010
268 FLUID INTAKE REDUCED 5 0.0010
269 THYROIDITIS 3 0.0010
270 OSTEOLYSIS 2 0.0010
271 PHLEBITIS 5 0.0010
272 SMALL INTESTINAL OBSTRUCTION 12 0.0010
273 DIVERTICULAR PERFORATION 2 0.0010
274 CAPILLARY LEAK SYNDROME 2 0.0010
275 NEUTROPENIC COLITIS 2 0.0010
276 SKIN NECROSIS 5 0.0010
277 EMBOLISM 8 0.0010
278 GASTROINTESTINAL PERFORATION 4 0.0010
279 INFUSION SITE PRURITUS 3 0.0009
280 LOOSE TOOTH 3 0.0009
281 HYPERPHOSPHATAEMIA 2 0.0009
282 ANAL ABSCESS 5 0.0009
283 METASTATIC NEOPLASM 4 0.0009
284 GINGIVITIS 5 0.0009
285 ALTERED STATE OF CONSCIOUSNESS 20 0.0009
286 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
287 HEPATIC NEOPLASM 3 0.0009
288 PANCYTOPENIA 51 0.0009
289 METASTASES TO LIVER 16 0.0009
290 DEVICE RELATED INFECTION 14 0.0009
291 BACTERIAL TEST POSITIVE 2 0.0009
292 METASTASES TO SPINE 3 0.0009
293 TONGUE ULCERATION 3 0.0009
294 HYPONATRAEMIA 50 0.0009
295 GASTROINTESTINAL HYPOMOTILITY 2 0.0009
296 ASPARTATE AMINOTRANSFERASE INCREASED 47 0.0009
297 LEUKOCYTOSIS 16 0.0009
298 BLOOD LOSS ANAEMIA 2 0.0009
299 PERONEAL NERVE PALSY 5 0.0009
300 METASTASES TO MENINGES 2 0.0009
301 EYE MOVEMENT DISORDER 6 0.0009
302 OXYGEN SATURATION DECREASED 49 0.0009
303 COLITIS 33 0.0009
304 CYTOMEGALOVIRUS COLITIS 2 0.0009
305 PLATELET COUNT DECREASED 92 0.0009
306 HYPOPHAGIA 22 0.0009
307 RESPIRATORY TRACT INFECTION VIRAL 2 0.0009
308 ROSACEA 4 0.0009
309 NECROTISING FASCIITIS 3 0.0009
310 SKIN TIGHTNESS 4 0.0008
311 FIBRIN D DIMER INCREASED 3 0.0008
312 CARDIAC TAMPONADE 4 0.0008
313 FACIAL BONES FRACTURE 3 0.0008
314 RADIUS FRACTURE 2 0.0008
315 BONE LESION 3 0.0008
316 VISUAL FIELD DEFECT 6 0.0008
317 ATELECTASIS 8 0.0008
318 RASH VESICULAR 4 0.0008
319 GUILLAIN-BARRE SYNDROME 4 0.0008
320 MONOCYTE COUNT INCREASED 3 0.0008
321 ADRENAL INSUFFICIENCY 10 0.0008
322 DECREASED APPETITE 191 0.0008
323 HAEMATOLOGICAL INFECTION 2 0.0008
324 THROAT TIGHTNESS 22 0.0008
325 HYPERVOLAEMIA 4 0.0008
326 ABDOMINAL TENDERNESS 4 0.0008
327 FOREIGN BODY SENSATION IN EYES 5 0.0008
328 ABDOMINAL INFECTION 2 0.0008
329 AORTIC ARTERIOSCLEROSIS 2 0.0008
330 HAEMOLYSIS 6 0.0008
331 BLOOD CHLORIDE DECREASED 2 0.0008
332 OROPHARYNGEAL DISCOMFORT 7 0.0008
333 EPIGASTRIC DISCOMFORT 3 0.0008
334 BLOOD ALKALINE PHOSPHATASE INCREASED 19 0.0008
335 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
336 HYPERTHYROIDISM 11 0.0008
337 BLOOD LACTIC ACID INCREASED 4 0.0008
338 BLOOD LACTATE DEHYDROGENASE INCREASED 12 0.0008
339 PANCREATITIS ACUTE 17 0.0008
340 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
341 OESOPHAGEAL CANDIDIASIS 3 0.0008
342 BLOOD POTASSIUM ABNORMAL 2 0.0007
343 ASCITES 22 0.0007
344 COMPRESSION FRACTURE 4 0.0007
345 DYSARTHRIA 28 0.0007
346 BLOOD SODIUM INCREASED 2 0.0007
347 VITAMIN B12 DEFICIENCY 3 0.0007
348 BLOOD BILIRUBIN INCREASED 20 0.0007
349 GASTRIC ULCER 14 0.0007
350 INVASIVE DUCTAL BREAST CARCINOMA 2 0.0007
351 BLOOD PHOSPHORUS INCREASED 2 0.0007
352 ANAPHYLACTOID REACTION 3 0.0007
353 ACUTE CORONARY SYNDROME 6 0.0007
354 TOXIC EPIDERMAL NECROLYSIS 11 0.0007
355 CONSTIPATION 156 0.0007
356 INTESTINAL PERFORATION 8 0.0007
357 BLOOD TEST ABNORMAL 10 0.0007
358 MUSCULOSKELETAL CHEST PAIN 11 0.0007
359 HOSPICE CARE 7 0.0007
360 HYPERPYREXIA 3 0.0007
361 FLUSHING 72 0.0007
362 NEUTROPHIL COUNT ABNORMAL 2 0.0007
363 OXYGEN SATURATION ABNORMAL 2 0.0007
364 PANCREATIC CARCINOMA METASTATIC 2 0.0007
365 BRONCHOSPASM 10 0.0007
366 LUNG CANCER METASTATIC 2 0.0007
367 METASTASES TO LUNG 8 0.0007
368 PYELONEPHRITIS 6 0.0007
369 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
370 MONOPLEGIA 3 0.0007
371 DIVERTICULUM INTESTINAL 3 0.0007
372 NAIL DISORDER 6 0.0007
373 PURPURA 6 0.0007
374 SEROTONIN SYNDROME 13 0.0007
375 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
376 ODYNOPHAGIA 4 0.0007
377 PAPILLOEDEMA 3 0.0007
378 SUSPECTED OFF LABEL USE 3 0.0007
379 INCONTINENCE 7 0.0007
380 HAEMATOCRIT DECREASED 13 0.0007
381 DYSAESTHESIA 2 0.0007
382 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
383 CHRONIC MYELOID LEUKAEMIA 3 0.0006
384 PORTAL HYPERTENSION 2 0.0006
385 DEHYDRATION 86 0.0006
386 SKIN REACTION 9 0.0006
387 BLOOD CREATININE DECREASED 2 0.0006
388 LYMPHOPENIA 9 0.0006
389 BLEPHAROSPASM 4 0.0006
390 HYPOCALCAEMIA 12 0.0006
391 NON-CARDIAC CHEST PAIN 2 0.0006
392 PNEUMOTHORAX 10 0.0006
393 TACHYCARDIA 56 0.0006
394 SEPSIS 70 0.0006
395 PNEUMONIA VIRAL 2 0.0006
396 ORAL PAIN 14 0.0006
397 COLD SWEAT 11 0.0006
398 ACUTE RESPIRATORY FAILURE 12 0.0006
399 NEPHROPATHY TOXIC 7 0.0006
400 PROCTALGIA 4 0.0006
401 METASTASES TO CENTRAL NERVOUS SYSTEM 8 0.0006
402 PORTAL VEIN THROMBOSIS 2 0.0006
403 GASTROENTERITIS 9 0.0006
404 LIVER ABSCESS 2 0.0006
405 ANAPHYLACTIC REACTION 34 0.0006
406 HYPOVENTILATION 2 0.0006
407 HAEMATURIA 21 0.0006
408 ASPHYXIA 5 0.0006
409 DISEASE PROGRESSION 72 0.0006
410 STAPHYLOCOCCAL SEPSIS 3 0.0006
411 ELECTROLYTE IMBALANCE 7 0.0006
412 VASCULITIS 7 0.0006
413 MULTIPLE ORGAN DYSFUNCTION SYNDROME 17 0.0006
414 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
415 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
416 KLEBSIELLA INFECTION 3 0.0006
417 INFUSION SITE ERYTHEMA 5 0.0006
418 CANDIDA INFECTION 10 0.0006
419 NEOPLASM RECURRENCE 2 0.0006
420 HEPATIC CYST 2 0.0006
421 CHOLECYSTITIS 7 0.0006
422 ALANINE AMINOTRANSFERASE INCREASED 36 0.0006
423 INTERSTITIAL LUNG DISEASE 28 0.0006
424 DELIRIUM 20 0.0006
425 PLEURAL EFFUSION 35 0.0006
426 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
427 ACUTE KIDNEY INJURY 88 0.0006
428 SEPTIC SHOCK 25 0.0006
429 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
430 HYPERCALCAEMIA 7 0.0006
431 PULMONARY TOXICITY 4 0.0006
432 METASTASIS 4 0.0006
433 NAUSEA 442 0.0006
434 VOMITING 262 0.0006
435 MYOSITIS 5 0.0006
436 FEELING HOT 34 0.0006
437 BLOOD PHOSPHORUS DECREASED 2 0.0005
438 INTESTINAL ISCHAEMIA 3 0.0005
439 HYPOMANIA 2 0.0005
440 UNRESPONSIVE TO STIMULI 14 0.0005
441 TASTE DISORDER 11 0.0005
442 RASH MACULO-PAPULAR 12 0.0005
443 HAEMOPTYSIS 15 0.0005
444 ERYTHEMA MULTIFORME 5 0.0005
445 SEDATION 14 0.0005
446 FLANK PAIN 5 0.0005
447 CHRONIC SINUSITIS 2 0.0005
448 GASTRITIS 14 0.0005
449 SKIN TOXICITY 3 0.0005
450 HEPATIC FAILURE 16 0.0005
451 CATHETER SITE INFECTION 2 0.0005
452 CIRCULATORY COLLAPSE 9 0.0005
453 HYPOTENSION 106 0.0005
454 MALIGNANT NEOPLASM PROGRESSION 54 0.0005
455 OEDEMA PERIPHERAL 64 0.0005
456 MOUTH ULCERATION 11 0.0005
457 RESPIRATORY FAILURE 38 0.0005
458 BLOOD URIC ACID INCREASED 3 0.0005
459 PERICARDIAL EFFUSION 12 0.0005
460 WHITE BLOOD CELL COUNT DECREASED 56 0.0005
461 ACUTE MYELOID LEUKAEMIA 8 0.0005
462 HYPERTRIGLYCERIDAEMIA 3 0.0005
463 CARDIAC ARREST 42 0.0005
464 PYREXIA 176 0.0005
465 CHEST DISCOMFORT 52 0.0005
466 CARDIO-RESPIRATORY ARREST 21 0.0005
467 HEPATITIS B 3 0.0005
468 FUNGAL SKIN INFECTION 2 0.0005
469 DECUBITUS ULCER 4 0.0005
470 EXTRAVASATION 2 0.0005
471 PARAESTHESIA ORAL 7 0.0005
472 HYPERKALAEMIA 17 0.0005
473 VENTRICULAR TACHYCARDIA 8 0.0005
474 AORTIC DISSECTION 2 0.0005
475 PERITONITIS 10 0.0005
476 INFUSION SITE EXTRAVASATION 3 0.0005
477 HEMIPLEGIA 4 0.0005
478 CHILLS 56 0.0005
479 PALLOR 13 0.0005
480 PHOTOPSIA 3 0.0005
481 PROTEINURIA 9 0.0005
482 ABDOMINAL PAIN 110 0.0005
483 DRUG INTERACTION 75 0.0005
484 PULMONARY MASS 7 0.0005
485 HYPOAESTHESIA ORAL 7 0.0005
486 HERPES SIMPLEX 3 0.0005
487 OCULAR ICTERUS 2 0.0005
488 SYNCOPE 46 0.0005
489 OESOPHAGITIS 5 0.0005
490 HYPOGAMMAGLOBULINAEMIA 3 0.0005
491 ONYCHOMYCOSIS 2 0.0005
492 LUNG INFILTRATION 4 0.0005
493 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
494 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
495 BLOOD CREATINE INCREASED 2 0.0005
496 STEVENS-JOHNSON SYNDROME 10 0.0004
497 URINARY RETENTION 15 0.0004
498 BREAST MASS 3 0.0004
499 SKIN INFECTION 5 0.0004
500 MENINGITIS ASEPTIC 2 0.0004
501 METASTASES TO LYMPH NODES 3 0.0004
502 FEEDING DISORDER 9 0.0004
503 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
504 EPISTAXIS 33 0.0004
505 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
506 C-REACTIVE PROTEIN INCREASED 16 0.0004
507 AKATHISIA 6 0.0004
508 MYOCARDIAL ISCHAEMIA 5 0.0004
509 ECCHYMOSIS 3 0.0004
510 CELLULITIS 22 0.0004
511 PNEUMONIA BACTERIAL 4 0.0004
512 NEOPLASM 5 0.0004
513 MUSCLE TWITCHING 10 0.0004
514 OVARIAN CANCER 4 0.0004
515 OROPHARYNGEAL PAIN 40 0.0004
516 LARGE INTESTINE PERFORATION 3 0.0004
517 CONJUNCTIVITIS 8 0.0004
518 GASTRITIS EROSIVE 2 0.0004
519 APPENDICITIS 4 0.0004
520 DIARRHOEA HAEMORRHAGIC 4 0.0004
521 ANAPHYLACTIC SHOCK 11 0.0004
522 ASTHENIA 158 0.0004
523 HYPOVOLAEMIC SHOCK 2 0.0004
524 HAEMATOCHEZIA 23 0.0004
525 DEEP VEIN THROMBOSIS 27 0.0004
526 FACE OEDEMA 7 0.0004
527 DERMATITIS BULLOUS 3 0.0004
528 HYPERCHOLESTEROLAEMIA 4 0.0004
529 SINUS BRADYCARDIA 4 0.0004
530 EAR PAIN 8 0.0004
531 PRESYNCOPE 10 0.0004
532 DIARRHOEA 264 0.0004
533 CYTOPENIA 5 0.0004
534 HEPATOMEGALY 4 0.0004
535 THERAPY CHANGE 4 0.0004
536 BREATH SOUNDS ABNORMAL 2 0.0004
537 NEOPLASM PROGRESSION 14 0.0004
538 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 2 0.0004
539 PROTEIN URINE PRESENT 2 0.0004
540 HYDRONEPHROSIS 3 0.0004
541 CHROMATURIA 9 0.0004
542 ERYSIPELAS 2 0.0004
543 PRODUCTIVE COUGH 19 0.0004
544 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
545 TROPONIN INCREASED 3 0.0004
546 BONE MARROW FAILURE 8 0.0004
547 LIPASE INCREASED 3 0.0004
548 NEUTROPHIL COUNT INCREASED 4 0.0004
549 LYMPHOMA 6 0.0004
550 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
551 LUNG INFECTION 6 0.0004
552 FURUNCLE 3 0.0004
553 TRICUSPID VALVE INCOMPETENCE 3 0.0004
554 ATRIAL FLUTTER 3 0.0004
555 EATING DISORDER 8 0.0004
556 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
557 ACUTE MYOCARDIAL INFARCTION 11 0.0004
558 RHINITIS 3 0.0004
559 PNEUMONIA 120 0.0004
560 SHOCK HAEMORRHAGIC 3 0.0004
561 LYMPHADENOPATHY 13 0.0004
562 ABNORMAL FAECES 3 0.0004
563 WOUND INFECTION 4 0.0004
564 FAECALOMA 2 0.0004
565 LACRIMATION INCREASED 11 0.0004
566 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3 0.0004
567 GASTRIC ULCER HAEMORRHAGE 2 0.0004
568 ORAL DISCOMFORT 5 0.0004
569 BLOOD UREA INCREASED 6 0.0004
570 THROAT IRRITATION 16 0.0004
571 SENSATION OF FOREIGN BODY 3 0.0004
572 DYSPNOEA 201 0.0004
573 HAEMATEMESIS 9 0.0004
574 CHOLECYSTITIS ACUTE 2 0.0004
575 NEUTROPHILIA 2 0.0004
576 PRESCRIBED UNDERDOSE 7 0.0004
577 DRUG-INDUCED LIVER INJURY 11 0.0004
578 RED BLOOD CELL COUNT DECREASED 10 0.0003
579 SKIN HYPERPIGMENTATION 3 0.0003
580 SKIN ULCER 9 0.0003
581 CHEST PAIN 64 0.0003
582 RALES 2 0.0003
583 SPINAL OSTEOARTHRITIS 3 0.0003
584 DECREASED INTEREST 2 0.0003
585 FATIGUE 264 0.0003
586 RESPIRATORY RATE INCREASED 3 0.0003
587 BACK PAIN 78 0.0003
588 FLATULENCE 19 0.0003
589 JAUNDICE 9 0.0003
590 DERMATITIS 7 0.0003
591 ATRIAL FIBRILLATION 32 0.0003
592 RETCHING 7 0.0003
593 ENCEPHALOPATHY 8 0.0003
594 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
595 NEPHROPATHY 3 0.0003
596 THERAPY PARTIAL RESPONDER 5 0.0003
597 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
598 NASAL DRYNESS 2 0.0003
599 HYPERHIDROSIS 41 0.0003
600 PARAESTHESIA 50 0.0003
601 ERYTHEMA 65 0.0003
602 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
603 HYPOTHYROIDISM 10 0.0003
604 ENTERITIS 2 0.0003
605 HYPERTENSION 66 0.0003
606 HAEMOGLOBIN ABNORMAL 2 0.0003
607 ERUCTATION 6 0.0003
608 HAEMORRHOIDS 6 0.0003
609 BONE PAIN 18 0.0003
610 PHARYNGEAL SWELLING 3 0.0003
611 RENAL TUBULAR NECROSIS 3 0.0003
612 METASTASES TO BONE 5 0.0003
613 URINARY INCONTINENCE 9 0.0003
614 IMMUNE SYSTEM DISORDER 4 0.0003
615 STAPHYLOCOCCAL INFECTION 10 0.0003
616 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
617 CARDIAC FAILURE ACUTE 2 0.0003
618 COAGULOPATHY 5 0.0003
619 DYSGEUSIA 22 0.0003
620 POSTOPERATIVE WOUND INFECTION 2 0.0003
621 HEPATIC FUNCTION ABNORMAL 11 0.0003
622 TOOTH ABSCESS 3 0.0003
623 GINGIVAL BLEEDING 4 0.0003
624 ACUTE HEPATIC FAILURE 4 0.0003
625 EAR DISCOMFORT 3 0.0003
626 INTESTINAL OBSTRUCTION 11 0.0003
627 DIABETIC KETOACIDOSIS 7 0.0003
628 CONFUSIONAL STATE 47 0.0003
629 TEMPERATURE INTOLERANCE 3 0.0003
630 EMOTIONAL DISTRESS 35 0.0003
631 ENCEPHALITIS 2 0.0003
632 PAPULE 2 0.0003
633 DUODENAL ULCER 2 0.0003
634 CYSTITIS 9 0.0003
635 HAEMOGLOBIN DECREASED 29 0.0003
636 HEPATOCELLULAR INJURY 4 0.0003
637 EXTRAPYRAMIDAL DISORDER 7 0.0003
638 HYPOAESTHESIA 42 0.0003
639 SUBDURAL HAEMATOMA 4 0.0003
640 BREAST CANCER METASTATIC 3 0.0003
641 SEIZURE 32 0.0003
642 GENERAL PHYSICAL HEALTH DETERIORATION 32 0.0003
643 OEDEMA 15 0.0003
644 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
645 SKIN LACERATION 3 0.0003
646 FAECES SOFT 2 0.0003
647 MELAENA 6 0.0003
648 ANGIOEDEMA 12 0.0003
649 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
650 PRODUCT USE IN UNAPPROVED INDICATION 67 0.0003
651 URINARY TRACT INFECTION 46 0.0003
652 HEPATOTOXICITY 6 0.0003
653 COLON CANCER 4 0.0003
654 IMMUNODEFICIENCY 4 0.0003
655 ABDOMINAL DISTENSION 28 0.0003
656 HAEMORRHAGE INTRACRANIAL 4 0.0003
657 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
658 DYSPNOEA EXERTIONAL 10 0.0003
659 MITRAL VALVE INCOMPETENCE 3 0.0003
660 POLLAKIURIA 11 0.0003
661 GASTROINTESTINAL HAEMORRHAGE 22 0.0003
662 BLOOD CREATININE INCREASED 17 0.0003
663 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
664 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
665 PRESCRIBED OVERDOSE 5 0.0003
666 SWOLLEN TONGUE 8 0.0003
667 SPLENOMEGALY 3 0.0003
668 WEIGHT DECREASED 71 0.0003
669 RESPIRATORY ARREST 7 0.0003
670 DYSPHAGIA 24 0.0003
671 ATAXIA 3 0.0003
672 PULMONARY EMBOLISM 24 0.0003
673 MENTAL STATUS CHANGES 7 0.0003
674 LOW BIRTH WEIGHT BABY 2 0.0003
675 ULCER 4 0.0003
676 BLOOD DISORDER 2 0.0002
677 MIOSIS 2 0.0002
678 RENAL FAILURE 33 0.0002
679 FULL BLOOD COUNT DECREASED 5 0.0002
680 HYPERGLYCAEMIA 9 0.0002
681 RESTLESSNESS 9 0.0002
682 PULMONARY OEDEMA 11 0.0002
683 CEREBRAL INFARCTION 6 0.0002
684 DYSURIA 9 0.0002
685 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
686 GENERALISED OEDEMA 3 0.0002
687 TOOTH EXTRACTION 3 0.0002
688 CYTOMEGALOVIRUS INFECTION 4 0.0002
689 EOSINOPHIL COUNT INCREASED 2 0.0002
690 RHABDOMYOLYSIS 10 0.0002
691 DYSPHONIA 14 0.0002
692 DRUG INTOLERANCE 23 0.0002
693 LABORATORY TEST ABNORMAL 7 0.0002
694 WHEEZING 14 0.0002
695 RENAL FAILURE ACUTE 10 0.0002
696 HEPATITIS 6 0.0002
697 INFUSION SITE PAIN 3 0.0002
698 BLOOD POTASSIUM DECREASED 7 0.0002
699 MUSCULOSKELETAL DISCOMFORT 4 0.0002
700 BLOOD MAGNESIUM DECREASED 2 0.0002
701 RESPIRATORY TRACT INFECTION 6 0.0002
702 PLATELET COUNT INCREASED 3 0.0002
703 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
704 ORTHOSTATIC HYPOTENSION 4 0.0002
705 OFF LABEL USE 201 0.0002
706 DEAFNESS 6 0.0002
707 SPEECH DISORDER 12 0.0002
708 BLOOD PRESSURE INCREASED 35 0.0002
709 ABDOMINAL PAIN UPPER 47 0.0002
710 EOSINOPHILIA 4 0.0002
711 HYPERSENSITIVITY 42 0.0002
712 LIMB DISCOMFORT 7 0.0002
713 DRUG ERUPTION 4 0.0002
714 TRANSAMINASES INCREASED 5 0.0002
715 RASH 98 0.0002
716 ISCHAEMIC STROKE 4 0.0002
717 FACIAL PAIN 2 0.0002
718 DEATH 190 0.0002
719 PERIPHERAL COLDNESS 3 0.0002
720 RESPIRATORY DISTRESS 6 0.0002
721 LACTIC ACIDOSIS 7 0.0002
722 HEPATIC STEATOSIS 4 0.0002
723 BACTERIAL INFECTION 4 0.0002
724 DEFORMITY 2 0.0002
725 PAIN IN JAW 6 0.0002
726 THROMBOSIS 17 0.0002
727 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
728 RASH ERYTHEMATOUS 10 0.0002
729 HYPOACUSIS 9 0.0002
730 PANCREATIC CARCINOMA 6 0.0002
731 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
732 LIVER FUNCTION TEST ABNORMAL 6 0.0002
733 APATHY 3 0.0002
734 PARKINSONISM 2 0.0002
735 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
736 MUSCULAR WEAKNESS 23 0.0002
737 OESOPHAGEAL CARCINOMA 6 0.0002
738 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
739 OSTEONECROSIS OF JAW 5 0.0002
740 GASTROINTESTINAL DISORDER 18 0.0002
741 ANXIETY 57 0.0002
742 SALIVARY HYPERSECRETION 2 0.0002
743 URTICARIA 33 0.0002
744 DYSKINESIA 8 0.0002
745 NECK PAIN 11 0.0002
746 DISCOMFORT 12 0.0002
747 TINNITUS 9 0.0002
748 DYSPEPSIA 19 0.0002
749 EJECTION FRACTION DECREASED 3 0.0002
750 HAEMATOMA 5 0.0002
751 PRURITUS 74 0.0002
752 COUGH 54 0.0002
753 DIZZINESS 96 0.0002
754 CYANOSIS 3 0.0002
755 JOINT STIFFNESS 5 0.0002
756 RENAL IMPAIRMENT 16 0.0002
757 PANCREATITIS 10 0.0002
758 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 34 0.0002
759 PREMATURE DELIVERY 3 0.0002
760 BREAST PAIN 2 0.0002
761 CARDIAC FAILURE 15 0.0002
762 CARDIAC FAILURE CONGESTIVE 15 0.0002
763 SLEEP DISORDER 13 0.0002
764 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
765 CHOLELITHIASIS 6 0.0002
766 ASPIRATION 2 0.0002
767 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
768 MANIA 3 0.0002
769 SKIN DISORDER 6 0.0002
770 PAIN IN EXTREMITY 53 0.0002
771 LOSS OF CONSCIOUSNESS 23 0.0002
772 FISTULA 2 0.0002
773 HEMIPARESIS 3 0.0002
774 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
775 SCAR 3 0.0002
776 INFLAMMATION 9 0.0002
777 SHOCK 4 0.0002
778 LETHARGY 10 0.0002
779 GASTRIC HAEMORRHAGE 2 0.0002
780 ABDOMINAL DISCOMFORT 29 0.0002
781 LOCAL SWELLING 3 0.0002
782 NEUROTOXICITY 3 0.0002
783 MYALGIA 29 0.0002
784 BRADYCARDIA 9 0.0002
785 DISEASE RECURRENCE 8 0.0002
786 THIRST 3 0.0002
787 HYPERLIPIDAEMIA 2 0.0002
788 INFECTION 24 0.0002
789 APHASIA 5 0.0002
790 BLOOD PRESSURE DECREASED 11 0.0002
791 BONE DISORDER 3 0.0002
792 END STAGE RENAL DISEASE 3 0.0002
793 RECTAL HAEMORRHAGE 7 0.0002
794 CARDIOMEGALY 2 0.0002
795 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
796 AGRANULOCYTOSIS 3 0.0002
797 APPLICATION SITE IRRITATION 2 0.0002
798 PNEUMONIA ASPIRATION 4 0.0002
799 PHOTOPHOBIA 3 0.0002
800 BLOOD SODIUM DECREASED 3 0.0002
801 FRACTURE 3 0.0002
802 CONVULSION 9 0.0002
803 CHOLESTASIS 3 0.0002
804 THERAPY CESSATION 8 0.0002
805 NODULE 2 0.0002
806 NASAL CONGESTION 9 0.0002
807 VISION BLURRED 21 0.0002
808 TREMOR 25 0.0002
809 FEAR 4 0.0001
810 DRY MOUTH 12 0.0001
811 BLINDNESS 6 0.0001
812 RIB FRACTURE 3 0.0001
813 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
814 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
815 DIVERTICULITIS 4 0.0001
816 PULMONARY HYPERTENSION 3 0.0001
817 DEMENTIA 4 0.0001
818 WOUND 4 0.0001
819 LUNG DISORDER 7 0.0001
820 BLISTER 8 0.0001
821 SKIN EXFOLIATION 12 0.0001
822 HEADACHE 89 0.0001
823 OSTEOARTHRITIS 6 0.0001
824 DEPRESSION 32 0.0001
825 LIVER FUNCTION TEST INCREASED 3 0.0001
826 POOR QUALITY SLEEP 3 0.0001
827 RHINORRHOEA 9 0.0001
828 MYELODYSPLASTIC SYNDROME 2 0.0001
829 HYPOKINESIA 2 0.0001
830 FLUID RETENTION 7 0.0001
831 FLUID OVERLOAD 2 0.0001
832 MALAISE 60 0.0001
833 COVID-19 24 0.0001
834 GAIT DISTURBANCE 26 0.0001
835 LIVER DISORDER 6 0.0001
836 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
837 RESPIRATORY DISORDER 4 0.0001
838 MUSCULOSKELETAL PAIN 7 0.0001
839 PREMATURE BABY 4 0.0001
840 BLOOD COUNT ABNORMAL 2 0.0001
841 HEART RATE INCREASED 13 0.0001
842 MUSCLE SPASMS 24 0.0001
843 RASH PRURITIC 7 0.0001
844 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
845 CONTUSION 12 0.0001
846 UNDERDOSE 9 0.0001
847 LIVER INJURY 3 0.0001
848 OSTEONECROSIS 4 0.0001
849 OSTEOPOROSIS 5 0.0001
850 PAIN 74 0.0001
851 VISUAL ACUITY REDUCED 4 0.0001
852 AGEUSIA 3 0.0001
853 ARTHRALGIA 50 0.0001
854 VIRAL INFECTION 4 0.0001
855 LIP SWELLING 4 0.0001
856 HALLUCINATION 9 0.0001
857 ABDOMINAL PAIN LOWER 3 0.0001
858 CARDIOVASCULAR DISORDER 3 0.0001
859 PERIPHERAL SWELLING 18 0.0001
860 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
861 PARANOIA 2 0.0001
862 RASH GENERALISED 3 0.0001
863 APPLICATION SITE ERYTHEMA 3 0.0001
864 RASH MACULAR 4 0.0001
865 SOMNOLENCE 23 0.0001
866 AMENORRHOEA 2 0.0001
867 DEPRESSED MOOD 6 0.0001
868 THERAPY INTERRUPTED 8 0.0001
869 GOUT 2 0.0001
870 PAIN OF SKIN 3 0.0001
871 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
872 PALPITATIONS 13 0.0001
873 OSTEOMYELITIS 2 0.0001
874 PELVIC PAIN 2 0.0001
875 SKIN LESION 3 0.0001
876 CONDITION AGGRAVATED 33 0.0001
877 INJECTION SITE MASS 4 0.0001
878 FEELING COLD 3 0.0001
879 EYE SWELLING 4 0.0001
880 RENAL DISORDER 5 0.0001
881 OCULAR HYPERAEMIA 5 0.0001
882 HERPES ZOSTER 6 0.0001
883 PULMONARY FIBROSIS 2 0.0001
884 DYSTONIA 2 0.0001
885 HEPATIC ENZYME INCREASED 7 0.0001
886 INSOMNIA 27 0.0001
887 BLOOD PRESSURE ABNORMAL 2 0.0001
888 CEREBROVASCULAR ACCIDENT 17 0.0001
889 BURNING SENSATION 7 0.0001
890 EPILEPSY 3 0.0001
891 BODY TEMPERATURE INCREASED 2 0.0001
892 NASOPHARYNGITIS 18 0.0001
893 PRODUCT PREPARATION ERROR 2 0.0001
894 FEELING ABNORMAL 23 0.0001
895 HAEMORRHAGE 10 0.0001
896 MOOD SWINGS 3 0.0001
897 FAECES DISCOLOURED 2 0.0001
898 SWELLING FACE 6 0.0001
899 MENTAL DISORDER 4 0.0001
900 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
901 GLOSSODYNIA 2 0.0001
902 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
903 SKIN DISCOLOURATION 4 0.0001
904 COGNITIVE DISORDER 4 0.0001
905 SWELLING 8 0.0001
906 MIGRAINE 8 0.0001
907 MENTAL IMPAIRMENT 2 0.0001
908 NEURALGIA 2 0.0001
909 EXPOSURE DURING PREGNANCY 5 0.0001
910 MYOCARDIAL INFARCTION 14 0.0001
911 ACNE 6 0.0001
912 CHRONIC KIDNEY DISEASE 6 0.0001
913 GASTRIC CANCER 2 0.0001
914 SINUSITIS 8 0.0001
915 DRUG RESISTANCE 2 0.0001
916 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
917 DIPLOPIA 2 0.0001
918 PLASMA CELL MYELOMA 3 0.0001
919 DISORIENTATION 3 0.0001
920 FALL 25 0.0001
921 DRY SKIN 10 0.0001
922 NEOPLASM MALIGNANT 5 0.0001
923 JOINT SWELLING 9 0.0001
924 DRUG EFFECT DECREASED 4 0.0001
925 MOOD ALTERED 2 0.0001
926 LUNG NEOPLASM MALIGNANT 3 0.0001
927 VISUAL IMPAIRMENT 9 0.0001
928 PROCEDURAL PAIN 2 0.0001
929 TOXICITY TO VARIOUS AGENTS 12 0.0001
930 INJURY 5 0.0001
931 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
932 INTENTIONAL DOSE OMISSION 2 0.0001
933 EYE IRRITATION 4 0.0001
934 PRODUCT USE ISSUE 13 0.0001
935 IRRITABILITY 4 0.0001
936 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
937 ILL-DEFINED DISORDER 4 0.0001
938 MEMORY IMPAIRMENT 9 0.0001
939 EMOTIONAL DISORDER 2 0.0001
940 NERVOUS SYSTEM DISORDER 2 0.0001
941 ARRHYTHMIA 3 0.0001
942 METABOLIC ACIDOSIS 2 0.0001
943 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
944 MOVEMENT DISORDER 2 0.0001
945 NIGHT SWEATS 2 0.0001
946 EYE DISORDER 2 0.0001
947 INFLUENZA LIKE ILLNESS 5 0.0001
948 FUNGAL INFECTION 2 0.0001
949 GAIT INABILITY 2 0.0001
950 EYE PRURITUS 2 0.0001
951 WEIGHT INCREASED 13 0.0001
952 HEART RATE DECREASED 2 0.0001
953 DISTURBANCE IN ATTENTION 3 0.0001
954 PANIC ATTACK 2 0.0001
955 ACCIDENTAL OVERDOSE 2 0.0001
956 BRONCHITIS 4 0.0001
957 CARDIAC DISORDER 5 0.0001
958 HOT FLUSH 4 0.0001
959 PRODUCT SUBSTITUTION ISSUE 3 0.0001
960 SURGERY 3 0.0001
961 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
962 ROAD TRAFFIC ACCIDENT 2 0.0000
963 BLOOD GLUCOSE INCREASED 9 0.0000
964 BALANCE DISORDER 4 0.0000
965 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
966 INFLUENZA 5 0.0000
967 ADVERSE DRUG REACTION 4 0.0000
968 PRODUCT QUALITY ISSUE 6 0.0000
969 DEVICE MALFUNCTION 3 0.0000
970 COLORECTAL CANCER 2 0.0000
971 SKIN BURNING SENSATION 3 0.0000
972 MOBILITY DECREASED 3 0.0000
973 AGITATION 3 0.0000
974 DRY EYE 2 0.0000
975 DIABETES MELLITUS 3 0.0000
976 HOSPITALISATION 6 0.0000
977 OVERDOSE 8 0.0000
978 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
979 TREATMENT FAILURE 3 0.0000
980 DRUG INEFFECTIVE 47 0.0000
981 RHEUMATOID ARTHRITIS 4 0.0000
982 MUSCULOSKELETAL STIFFNESS 3 0.0000
983 CATARACT 2 0.0000
984 ADVERSE EVENT 3 0.0000
985 NO ADVERSE EVENT 5 0.0000
986 ARTHRITIS 2 0.0000
987 INCORRECT DOSE ADMINISTERED 5 0.0000
988 BREAST CANCER 2 0.0000
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
990 ILLNESS 2 0.0000
991 PRODUCT DOSE OMISSION ISSUE 5 0.0000
992 PSORIASIS 2 0.0000
993 INJECTION SITE PAIN 2 0.0000